A new model of human prostate cancer, the PAC120 xenograft;Un nouveau modèle de cancer humain de prostate, PAC120

Pathologie Biologie

Volumn 51, Issue 1, 2003, Pages 1-4

  Legrier, M E ^a   De Pinieux, G ^b   Poirson Bichat, F ^a   Apiou, F ^a   Dutrillaux, A M ^a   Boye, K ^a   Sihassen, A ^a   Lidereau, R ^c   Bara, J ^d   Arvelo, F ^a   Dutrillaux, B ^a   Poupon, M F ^a  

^a CNRS   (France)

^b Anatomie Pathologique ^*  (France)

^c CENTRE RENÉ HUGUENIN   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Genetic alterations; Hormone independence; Morphological differentiation; Prostate cancer; Therapy

Indexed keywords

ANTIANDROGEN; DOCETAXEL; FE 200486; GONADOTROPIN ANTAGONIST; UNCLASSIFIED DRUG;

ADENOCARCINOMA; CELL STRAIN; CELL STRAIN PAC120; CHROMOSOME ABERRATION; DRUG MECHANISM; GENE EXPRESSION; GENETIC VARIABILITY; HORMONE ACTION; HUMAN; NONHUMAN; PHENOTYPE; PROSTATE CANCER; REVIEW; TUMOR XENOGRAFT;

EID: 0345268687     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00314-0     Document Type: Article

References (7)

1. van Weerden WM, et al. Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 1996;149:1055-62.
2. Royai R, Lange PH, Vessella R. Preclinical models of prostate cancer. Semin Oncol 1996;23(6 Suppl 14):35-40.
3. de Pinieux G, et al. Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. Am J Pathol 2001;159:753-64.
4. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29:117-34.
5. Isaacs JT. The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer. Prostate 1984;5:1-17.
6. Yeh S, et al. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci USA 1999;96:5458-63.
7. Zinda MJ, et al. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res 2001;7:2475-9.